94994-25-9

Basic information

• Product Name: 4-Formyl-bicyclo[2.2.2]octane-1-carboxylic acid methyl ester
• Synonyms: 4-Formyl-bicyclo[2.2.2]octane-1-carboxylic acid methyl ester;Methyl 4-formylbicyclo[2.2.2]octane-1-carboxylate
• CAS NO: 94994-25-9
• Molecular Formula: C₁₁H₁₆O₃
• Molecular Weight: 196.24294
• Mol File: 94994-25-9.mol
• Article Data: 15

Chemical Properties

• Boiling Point: 261℃
• Flash Point: 109℃
• Appearance: /
• Density: 1.252
• Storage Temp.: Inert atmosphere,Store in freezer, under -20°C
• Solubility: Chloroform (Sparingly), Ethyl Acetate (Slightly)
• CAS DataBase Reference: 4-Formyl-bicyclo[2.2.2]octane-1-carboxylic acid methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 4-Formyl-bicyclo[2.2.2]octane-1-carboxylic acid methyl ester(94994-25-9)
• EPA Substance Registry System: 4-Formyl-bicyclo[2.2.2]octane-1-carboxylic acid methyl ester(94994-25-9)

Safety Data

• Hazardous Substances Data: 94994-25-9(Hazardous Substances Data)

Usage

General Description

4-Formyl-bicyclo[2.2.2]octane-1-carboxylic acid methyl ester is a chemical compound that is commonly used in organic synthesis and pharmaceutical research. It is an ester derivative of bicyclo[2.2.2]octane-1-carboxylic acid, containing a formyl group and a methyl ester group. 4-Formyl-bicyclo[2.2.2]octane-1-carboxylic acid methyl ester is known for its unique molecular structure and potential applications in medicinal chemistry. Its chemical properties and reactivity make it an important building block for the synthesis of various organic molecules and pharmaceutical drugs. Furthermore, the compound's structural features may contribute to its biological activity and potential therapeutic effects, making it a valuable target for drug discovery and development.

Upstream product

• 110371-29-4 methyl 4-(carbonochloridoyl)bicyclo[2.2.2]octane-1-carboxylate 
• 953-69-5 4-phenylbicyclo<2.2.2>octane-1-carboxylic acid 
• 23062-52-4 methyl 4-phenylbicyclo<2.2.2>octane-1-carboxylate 
• 1459-96-7 dimethyl bicyclo[2.2.2]octane-1,4-dicarboxylate 
• 94-60-0 dimethyl 1,4-cyclohexane dicarboxylate 
• 18720-35-9 bicyclo[2.2.2]octane-1,4-dicarboxylic acid monomethyl ester 
• 94994-15-7 4-hydroxymethyl-bicyclo[2.2.2]octane-1-carboxylic acid methyl ester 

Downstream Products

• 719274-69-8 methyl 1-[(E)-3-oxo-3-phenylmethoxyprop-1-enyl]-4-bicyclo[2.2.2]octanecarboxylate 
• 340021-17-2 3-(4-(2,6-dioxo-1,3-dipropyl-2,3,6,9-tetrahydro-1H-purin-8-yl)bicyclo[2.2.2]octan-1-yl)propanoic acid 
• 959958-69-1 3-(4-(6-amino-2,4-dioxo-1-propyl-3-heptadeuteriopropyl-1,2,3,4-tetrahydro-pyrimidin-5-ylcarbamoyl)-bicyclo[2.2.2]oct-1-yl)propionic acid methyl ester 
• 96102-85-1 4-formyl-bicyclo[2.2.2]octane-1-carboxylic acid 
• 719274-47-2 2-{4-[3-(2-methyl-1,3-dioxolan-2-yl)propyl]bicyclo[2.2.2]oct-1-yl}-5-[2-(trifluoromethyl)phenyl]-1,3,4-oxadiazole 
• 719274-52-9 2-(2-chloro-4-methoxyphenyl)-5-{4-[3-(2-methyl-1,3-dioxolan-2-yl)propyl]bicyclo[2.2.2]oct-1-yl}-1,3,4-oxadiazole 
• 719274-50-7 5-(4-{5-[2-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-yl}bicyclo[2.2.2]oct-1-yl)pentan-2-ol 
• 719274-49-4 5-(4-{5-[2-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-yl}bicyclo[2.2.2]oct-1-yl)pentan-2-one 
• 719274-53-0 5-{4-[5-(2-chloro-4-methoxyphenyl)-1,3,4-oxadiazol-2-yl]bicyclo[2.2.2]oct-1-yl}pentan-2-one 
• 719274-54-1 5-{4-[5-(2-chloro-4-methoxyphenyl)-1,3,4-oxadiazol-2-yl]bicyclo[2.2.2]oct-1-yl}pentan-2-ol 
• 719274-77-8 3-{4-[3-(ethylsulfonyl)propyl]bicyclo[2.2.2]oct-1-yl}-4-methyl-5-[2-(trifluoromethyl)phenyl]-4H-1,2,4-triazole hydrochloride 
• 719272-72-7 5-(4-{1-methyl-5-[2-(trifluoromethyl)phenyl]-1-H-1,2,4-triazol-3-yl}bicyclo[2.2.2]oct-1-yl)pentan-2-ol 
• 719272-78-3 3-{4-[2-(Ethylsulfonyl)ethyl]bicyclo[2.2.2]oct-1-yl}-4-methyl-5-[2-(trifluoromethyl)phenyl]-4H-1,2,4-triazole 
• 719272-74-9 5-{4-[5-(2-chloro-4-hydroxyphenyl)-4-methyl-4H-1,2,4-triazol-3-yl]bicyclo[2.2.2]oct-1-yl}pentan-2-one 

Relevant articles and documents

MONOCARBOXYLIC ACID TRANSPORTER 4 (MCT4) MODULATORS AND USES THEREOF

Disclosed herein are compounds, compositions, and methods for modulating the monocarboxylic acid transporter 4 (MCT4) with the compounds and compositions disclosed herein. Also described are methods of treating diseases or conditions that are mediated by

SUBSTITUTED BICYCLIC COMPOUNDS AS FARNESOID X RECEPTOR MODULATORS

Disclosed are compounds of Formula (I): or a stereoisomer, a tautomer, or a salt or solvate thereof, wherein Q is C2-6 alkenyl or C2-6 alkynyl, each substituted with zero to 2 R1; and the other variables are as defined herein. These compounds modulate the activity of farnesoid X receptor (FXR), for example, as agonists. Also disclosed are pharmaceutical compositions comprising these compounds and methods of treating a disease, disorder, or condition associated with FXR dysregulation, such as pathological fibrosis, transplant rejection, cancer, osteoporosis, and inflammatory disorders, by using the compounds and pharmaceutical compositions.

SUBSTITUTED BICYCLIC COMPOUNDS AS FARNESOID X RECEPTOR MODULATORS

Disclosed are compounds of Formula (I) or a stereoisomer, a tautomer, or a salt or solvate thereof, wherein all the variables are as defined herein. These compounds modulate the activity of farnesoid X receptor (FXR), for example, as agonists. Also disclosed are pharmaceutical compositions comprising these compounds and methods of treating a disease, disorder, or condition associated with FXR dysregulation, such as pathological fibrosis, transplant rejection, cancer, osteoporosis, and inflammatory disorders, by using the compounds and pharmaceutical compositions.